A randomized phase II trial of TG4001 plus avelumab versus avelumab alone in recurrent/metastatic (R/M) human papilloma virus (HPV)-16 positive anogenital cancersC. Le Tourneau et al.AACR 2023Download the poster herePoster Presentation